<!-- wp:paragraph -->
<p><strong>"SCANDENS
PHARMACEUTİCAL İNDUSTRİES Ltd"</strong> - the first
pharmaceutical plant for the complete production cycle of Pharmaceutical
formulations in Azerbaijan was established in 2016. Construction of the plant
started in 2017.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
first stage of production involves solid medicines forms including tablets,
capsules and granules over the full production cycle from granulation to
finished products and batch release from its own Quality Control laboratory as
well as its high standard Quality system.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>The second stage will be for Manufacturing and release
of ointments and suppositories.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>The third stage is targeted to the sterilized products
- ampoules for injection and infusion solutions.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; "Scandens
Pharmaceuticals İndustries Ltd" offers large cooperation opportunities
with other pharmaceutical companies in the areas of producers of manufacturing
based on technology transfer, licensed production, and contract production.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
plant is designed by one of the leading consulting companies engaged in the
pharmaceutical field who has more than 400 pharmaceutical successfully
operating plants into their credit in various countries across the globe.</p>
<!-- /wp:paragraph -->

<!-- wp:paragraph -->
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Plant current designed &nbsp;production capacity in the first stage is 600
million tablets and 150 million capsules, which will provide the need for
tablet and capsule medicine forms of many therapeutic groups, such as
cardiology, antidiabetic, anti-tuberculosis, analgesic, anti-inflammatory and
others. More than 100 generic formulations are being planned to produce.</p>
<!-- /wp:paragraph -->